Business Context and Reporting Period
Company: LeMaitre Vascular, Inc. (LMAT)
Filing Type: Form 8-K (Current Report)
Date of Report: November 6, 2025
Reporting Period: Preliminary results for the quarter ended September 30, 2025.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This 8-K serves as a notification that preliminary results were issued via a press release (Exhibit 99.1), but the specific financial data points are not embedded in the body of this document.
Material Changes
No material changes or comparative financial data are detailed in the text of this filing. The document references a press release for operational and financial results but does not summarize the variances versus the prior comparable period.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The filing contains forward-looking statements based on management's preliminary expectations.
- Risks: Actual results may differ due to risks and uncertainties detailed in the "Risk Factors" section of the Company's most recent Form 10-K and subsequent filings.
- Disclaimer: The Company undertakes no obligation to update forward-looking statements to reflect new information or unanticipated events.
- Legal Status: Information in Item 2.02 and Exhibit 99.1 is furnished, not "filed," for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the actual preliminary financial figures for the quarter ended September 30, 2025.
- Consult the most recent Form 10-K for detailed risk factors referenced in this filing.
- Verify the trading symbol LMAT on The Nasdaq Global Market.
- Note that the financial data in this 8-K is preliminary and subject to change in the formal quarterly report.